Thermo Fisher Scientific (TMO) Cash from Investing Activities (2016 - 2025)
Thermo Fisher Scientific (TMO) has disclosed Cash from Investing Activities for 16 consecutive years, with $20.0 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Cash from Investing Activities rose 105.32% year-over-year to $20.0 million, compared with a TTM value of -$5.8 billion through Dec 2024, down 13.59%, and an annual FY2025 reading of -$4.0 billion, up 30.71% over the prior year.
- Cash from Investing Activities was $20.0 million for Q4 2024 at Thermo Fisher Scientific, up from -$3.6 billion in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $20.0 million in Q4 2024 and bottomed at -$18.7 billion in Q4 2021.
- Average Cash from Investing Activities over 5 years is -$1.8 billion, with a median of -$580.5 million recorded in 2021.
- The sharpest move saw Cash from Investing Activities crashed 2885.94% in 2021, then surged 105.32% in 2024.
- Year by year, Cash from Investing Activities stood at -$626.0 million in 2020, then plummeted by 2885.94% to -$18.7 billion in 2021, then skyrocketed by 97.19% to -$525.0 million in 2022, then increased by 28.38% to -$376.0 million in 2023, then skyrocketed by 105.32% to $20.0 million in 2024.
- Business Quant data shows Cash from Investing Activities for TMO at $20.0 million in Q4 2024, -$3.6 billion in Q3 2024, and -$253.0 million in Q2 2024.